Compliance & Ethics Predictions for 2010
The year that just ended was a momentous one for the compliance and ethics (C&E) field. It was marked, among other things, by the imposition of the largest criminal fine in U.S. history (in the Pfizer fraud-and-abuse prosecution), as well as the largest penalties ever imposed in cases involving OSHA, FERC and OFAC related violations. And, by all accounts, there is more – perhaps much more – to come.
At the same time, governmental bodies are speaking more clearly now than ever before about their C&E program expectations of companies. This was evidenced by:
How this last story plays out will, in my view, likely be the most important C&E issue overall in 2010, particularly when the OECD publishes C&E program best practices in June. But for any given company, the most important C&E issue will be the one that it either avoids (through having a strong program) or, conversely, that hits them square between the eyes.
Jump ahead 12 months: will you be able to say that your most significant C&E issue of the year was the one you avoided? A lot goes into the mix of creating C&E success, of course, but following the advice of the Vice Chair of the Sentencing Commission, as well as others in the government, to assess your program is as good a place to start as any. After all, just as medical checkups can play an important role in maintaining one’s physical health, C&E checkups – which is what assessments are – can do the same for a company’s compliance well being.



